2-chloro-6-nitro-3,4-dihydroquinazolin-4-one, 98%, 500mg

N-(1-phenylethyl)-2-(pyrrolidin-1-yl)quinazolin-4-aMine, 98%, 1g

4-Benzoyl-3-hydroxyphenyl methacrylate, 95+%, 1g

3-Ethyl-5-methylphenol, 95.0%, 1g

Di-tert-butyl piperazine-1,4-dicarboxylate, 95.0%, 100g

7-Bromo-4-chlorothieno[3,2-d]pyrimidine, 95.0%, 25g

1-Ethyl-3,5-dimethyl-1 H -pyrazol-4-ylamine hydrochloride, 95.0%, 1g

1-(Pyridin-2-yl)-1H-pyrazol-4-amine, 97%, 100mg

Leu-Leu-Leu-OH, 96.0%, 1g

2-((E)-3-Ethoxy-2-methyl-allylidene)-malononitrile, 95.0%, 1g

3-Ethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine, 95.0%, 10g

4-Vinylbenzenesulfonamide, 97% mix TBC as stabilizer, 100mg

Simbolo di avvertenza secondo ISO 7010 Etichetta individuale, Campo magnetico, Lunghezza lato 200 mm, 1 pezzo